![]() |
Volumn 3, Issue 5, 2001, Pages 293-298
|
Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): Requirement for GM-CSF in the effector phase of disease
|
Author keywords
Antibodies; In vivo animal models; Inflammatory mediators; Rheumatoid arthritis
|
Indexed keywords
ANTIGEN;
COLLAGEN;
COLLAGEN TYPE 2;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 1BETA;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTHRITIS;
ARTICLE;
CARTILAGE DEGENERATION;
CELLULAR IMMUNITY;
CONTROLLED STUDY;
DISEASE SEVERITY;
HISTOPATHOLOGY;
HUMORAL IMMUNITY;
IMMUNIZATION;
INFLAMMATORY DISEASE;
JOINT;
LIMB;
MALE;
MODULATION;
MOUSE;
MOUSE STRAIN;
NONHUMAN;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
ANIMALS;
ANKLE JOINT;
ANTIBODIES, BLOCKING;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, EXPERIMENTAL;
CARTILAGE, ARTICULAR;
COLLAGEN;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HINDLIMB;
IMMUNIZATION;
INTERLEUKIN-1;
LOCAL LYMPH NODE ASSAY;
LYMPHOCYTE ACTIVATION;
MALE;
MICE;
MICE, INBRED DBA;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0034851864
PISSN: 14659905
EISSN: None
Source Type: Journal
DOI: 10.1186/ar318 Document Type: Article |
Times cited : (161)
|
References (31)
|